Drugs Affecting Blood and Blood Formation Practice Questions

Q: Which recent oral direct thrombin inhibitor can be used for the prevention of stroke?

Dabigatran. **Explanation:** **Dabigatran** is the correct answer as it is a potent, competitive, and reversible **Direct Thrombin Inhibitor (DTI)**. Unlike older anticoagulants, it is administered orally as a prodrug (Dabigatran etexilate). It directly binds to the active site of both free and clot-bound thrombin (Factor IIa), preventing the conversion of fibrinogen to fibrin. It is FDA-approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. **Analysis of Incorrect Options:** * **Ximelagatran (B):** This was the first oral DTI developed, but it was withdrawn globally shortly after its release due to severe **hepatotoxicity** (elevation of liver enzymes). * **Lepirudin (C):** While this is a direct thrombin inhibitor (a recombinant derivative of hirudin), it is administered **parenterally** (IV), not orally. It was primarily used for Heparin-Induced Thrombocytopenia (HIT) but has been largely discontinued. * **Saxagliptin (D):** This is a **DPP-4 inhibitor** used in the management of Type 2 Diabetes Mellitus; it has no anticoagulant properties. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** The specific reversal agent for Dabigatran is **Idarucizumab** (a humanized monoclonal antibody fragment). * **Monitoring:** Unlike Warfarin, routine INR monitoring is not required for Dabigatran. However, it can prolong aPTT, ECT (Ecarin Clotting Time), and TT (Thrombin Time). * **Excretion:** It is primarily eliminated by the **kidneys**; thus, dose adjustment or avoidance is necessary in severe renal impairment. * **Comparison:** Do not confuse "Gatrans" (Direct Thrombin/IIa inhibitors) with "Xabans" (Direct Factor Xa inhibitors like Rivaroxaban and Apixaban).

Q: A patient has subclinical folate deficiency. Which of the following drugs cannot precipitate megaloblastic anemia in this patient?

Chloroquine. **Explanation:** The correct answer is **Chloroquine**. To understand this, we must distinguish between drugs that interfere with folate metabolism and those that do not. **Why Chloroquine is the Correct Answer:** Chloroquine is an aminoquinoline used primarily for malaria and rheumatoid arthritis. Unlike many other antimicrobials, it **does not inhibit the dihydrofolate reductase (DHFR) enzyme** nor does it interfere with the absorption or utilization of Vitamin B12 or Folic acid. Therefore, it does not precipitate megaloblastic anemia, even in patients with borderline folate levels. **Analysis of Incorrect Options:** * **Alcohol:** Chronic alcohol consumption is a leading cause of folate deficiency. It interferes with folate absorption in the jejunum, impairs its storage in the liver, and increases renal excretion. * **Metformin:** This first-line antidiabetic drug is well-known to cause **Vitamin B12 deficiency** by interfering with calcium-dependent absorption of the B12-intrinsic factor complex in the terminal ileum. Long-term use can lead to megaloblastic anemia. * **Proguanil:** This is an antimalarial biguanide that acts as a **DHFR inhibitor**. By preventing the conversion of dihydrofolate to tetrahydrofolate (the active form), it directly impairs DNA synthesis, potentially triggering megaloblastic changes in folate-deficient individuals. **High-Yield Clinical Pearls for NEET-PG:** * **DHFR Inhibitors (The "M-P-T" Rule):** **M**ethotrexate, **P**yrimethamine, **P**roguanil, and **T**rimethoprim are classic triggers for megaloblastic anemia. * **Phenytoin:** Also causes folate deficiency by inhibiting the enzyme *folate conjugase* in the gut. * **Leucovorin Rescue:** Folinic acid (Leucovorin) is used to bypass DHFR inhibition caused by Methotrexate, whereas folic acid itself would be ineffective.

Q: All of the following are seen with heparin therapy except?

Skin necrosis. ### Explanation The correct answer is **A. Skin necrosis**. While skin necrosis is a classic dermatological complication of anticoagulant therapy, it is characteristically associated with **Warfarin**, not Heparin. Warfarin-induced skin necrosis occurs due to a rapid decline in Protein C levels (which has a short half-life), leading to a transient hypercoagulable state and microvascular thrombosis in the skin. **Analysis of Options:** * **Thrombosis and thrombocytopenia (Option B):** These are the hallmarks of **Heparin-Induced Thrombocytopenia (HIT) Type II**. This is an immune-mediated reaction where IgG antibodies form against the Heparin-Platelet Factor 4 (PF4) complex. Paradoxically, this leads to platelet activation and life-threatening arterial or venous **thrombosis**. * **Osteoporosis (Option C):** Long-term heparin therapy (usually >3 months) can lead to decreased bone density and spontaneous fractures. Heparin increases osteoclast activity and decreases osteoblast formation. * **Alopecia (Option D):** Transient hair loss is a documented, though less common, side effect of heparin therapy, occurring weeks after the initiation of treatment. **High-Yield Clinical Pearls for NEET-PG:** 1. **Antidote:** The specific antagonist for Heparin is **Protamine Zinc Sulfate** (1 mg neutralizes 100 units of heparin). 2. **Monitoring:** Unfractionated Heparin (UFH) is monitored using **aPTT**, whereas Low Molecular Weight Heparin (LMWH) usually does not require monitoring (except in pregnancy or renal failure, where **Factor Xa levels** are checked). 3. **Hyperkalemia:** Heparin can cause hyperkalemia by inhibiting aldosterone synthesis in the adrenal glands. 4. **HIT Management:** If HIT is suspected, stop all heparin immediately and switch to a direct thrombin inhibitor like **Argatroban** or **Lepirudin**.

Q: Alteplase differs from streptokinase in which of the following ways?

It activates plasminogen that is bound to fibrin.. **Explanation:** The core difference between Alteplase and Streptokinase lies in their **fibrin specificity**. **1. Why Option D is Correct:** Alteplase is a recombinant **Tissue Plasminogen Activator (t-PA)**. It is "fibrin-selective," meaning it preferentially binds to plasminogen that is already bound to a fibrin clot. This localized activation converts plasminogen to plasmin specifically at the site of the thrombus, minimizing systemic proteolysis. In contrast, Streptokinase is a non-specific activator that converts both circulating and clot-bound plasminogen, leading to a "systemic lytic state." **2. Why the Other Options are Incorrect:** * **Option A:** Alteplase has a very **short half-life** (~5 minutes) and usually requires a continuous infusion, whereas Streptokinase has a longer duration of action. * **Option B:** Alteplase is produced using **recombinant DNA technology** (originally derived from human melanoma cells, not kidney cells). Urokinase is the agent traditionally associated with human kidney cell cultures. * **Option C:** Alteplase is significantly **more expensive** than Streptokinase due to the complex recombinant manufacturing process. **3. High-Yield Clinical Pearls for NEET-PG:** * **Antigenicity:** Streptokinase is derived from *Beta-hemolytic Streptococci* and is **antigenic**. It can cause anaphylaxis and cannot be reused within 6–12 months due to neutralizing antibodies. Alteplase is non-antigenic. * **Mechanism:** Streptokinase does not have intrinsic enzymatic activity; it forms a 1:1 complex with plasminogen to activate it. Alteplase is a direct protease. * **Drug of Choice:** Due to its clot selectivity, Alteplase (or its derivatives like Tenecteplase) is preferred in the management of STEMI, acute ischemic stroke, and massive pulmonary embolism.

Q: All of the following are true about heparin except:

It can only be administered in vivo. The correct answer is B, as heparin is effective both in vivo (inside the body) and in vitro (outside the body). This is a high-yield distinction in pharmacology. 1. Why Option B is the correct "Except" choice: Heparin acts by activating Antithrombin III, which then inactivates clotting factors like Thrombin (IIa) and Factor Xa [1, 2, 3]. Since Antithrombin III is present in both circulating blood and collected blood samples, heparin can prevent clotting in test tubes, blood bags, and dialysis circuits. In contrast, oral anticoagulants like Warfarin act by inhibiting the synthesis of clotting factors in the liver; therefore, Warfarin works only in vivo. 2. Analysis of other options: * Option A: Protamine sulfate is the specific antidote for heparin [1, 3]. It is a strongly basic protein that neutralizes the acidic heparin molecule through ionic bonding (chemical antagonism). * Option C: Heparin is a large, highly ionized mucopolysaccharide [1]. It is not absorbed through the gastrointestinal mucosa and is degraded by gastric acid, making oral administration impossible. It must be given parenterally (IV or SC). * Option D: Heparin primarily affects the intrinsic and common pathways [3]. Therefore, the Activated Partial Thromboplastin Time (APTT) is the standard clinical test used to monitor its therapeutic efficacy. Clinical Pearls for NEET-PG: * Mechanism: Indirect thrombin inhibitor (requires Antithrombin III) [1, 2, 3]. * Safe in Pregnancy: Heparin does not cross the placenta (unlike Warfarin), making it the anticoagulant of choice during pregnancy. * Side Effects: Most common is bleeding; most unique is Heparin-Induced Thrombocytopenia (HIT) [3] and osteoporosis (on long-term use). * LMWH vs. UFH: Low Molecular Weight Heparin (e.g., Enoxaparin) primarily inhibits Factor Xa [1, 3] and does not require routine APTT monitoring.

Q: Warfarin embryopathy is due to the action of:

Osteocalcin. **Explanation:** Warfarin embryopathy (Fetal Warfarin Syndrome) occurs when warfarin is administered during the first trimester of pregnancy (specifically between 6–9 weeks of gestation). **Why Osteocalcin is the correct answer:** Warfarin is a vitamin K antagonist. It inhibits the enzyme **vitamin K epoxide reductase**, which is essential for the gamma-carboxylation of several proteins. One such protein is **osteocalcin** (bone Gla protein), which is synthesized by osteoblasts and is vital for normal bone and cartilage mineralization. When warfarin crosses the placenta, it prevents the carboxylation of osteocalcin, leading to defective bone formation. This results in the classic clinical features of warfarin embryopathy, most notably **stippled epiphyses** (chondrodysplasia punctata) and **nasal hypoplasia**. **Analysis of Incorrect Options:** * **A, B, and D (Osteophysin, Osteotensin, Osteogenin):** These are not the primary proteins involved in the vitamin K-dependent carboxylation pathway related to warfarin’s teratogenic mechanism. While "Osteogenin" (BMP-3) is involved in bone formation, it is not inhibited by vitamin K antagonism. **High-Yield Clinical Pearls for NEET-PG:** * **Critical Period:** 6th to 9th week of gestation. * **Clinical Features:** Nasal hypoplasia, depressed nasal bridge, stippled epiphyses, and limb hypoplasia. * **CNS Effects:** Exposure in later trimesters can cause CNS anomalies (microcephaly, optic atrophy) due to fetal hemorrhage, as warfarin crosses the placenta (unlike Heparin). * **Drug of Choice:** Low Molecular Weight Heparin (LMWH) is the preferred anticoagulant in pregnancy as it does not cross the placenta.

Q: In the management of pulmonary emboli, alteplase is infused for how long?

1-3 hours. **Explanation:** **Alteplase (rt-PA)** is a recombinant tissue plasminogen activator used for thrombolysis. In the management of acute massive pulmonary embolism (PE), the standard FDA-approved regimen is **100 mg administered as a continuous intravenous infusion over 2 hours.** This falls within the **1–3 hour** window, making Option A the correct choice. **Why Option A is correct:** The goal in PE is rapid recanalization of the occluded pulmonary artery to relieve right ventricular strain. Unlike the management of Acute Ischemic Stroke (where it is given over 60 minutes) or Myocardial Infarction (accelerated protocol over 90 minutes), the PE protocol specifically targets a 2-hour infusion to balance rapid clot lysis with the risk of major hemorrhage. **Why other options are incorrect:** * **Options B, C, and D:** These durations (4–12 hours) are too long for alteplase. Historically, older thrombolytics like Streptokinase or Urokinase were infused over 12–24 hours for PE. However, modern "short-course" thrombolysis with rt-PA is preferred because it is more effective at rapidly dissolving clots and carries a lower cumulative bleeding risk compared to prolonged infusions. **NEET-PG High-Yield Pearls:** * **Mechanism:** Alteplase converts plasminogen to plasmin; it is "fibrin-selective," meaning it preferentially activates plasminogen bound to a fibrin clot. * **Half-life:** Very short (~5 minutes), primarily cleared by the liver. * **Antidote:** In case of life-threatening bleed post-thrombolysis, use **Aminocaproic acid** or **Tranexamic acid**. * **Contraindication:** Always screen for absolute contraindications like recent intracranial hemorrhage, active internal bleeding, or recent ischemic stroke (within 3 months).

Question 1

Which recent oral direct thrombin inhibitor can be used for the prevention of stroke?

Accepted Answer

Dabigatran

Answer

Ximelagatran

Answer

Lepirudin

Answer

Saxagliptin

Question 2

A patient has subclinical folate deficiency. Which of the following drugs cannot precipitate megaloblastic anemia in this patient?

Accepted Answer

Chloroquine

Answer

Alcohol

Answer

Metformin

Answer

Proguanil

Question 3

Warfarin anticoagulants inhibit which of the following coagulation factors?

Accepted Answer

II, VII, IX, X

Answer

II, V, VII, IX

Answer

II, V, IX, X

Answer

II, IX, X, XIII

Question 4

All of the following are seen with heparin therapy except?

Accepted Answer

Skin necrosis

Answer

Thrombosis and thrombocytopenia

Answer

Osteoporosis

Answer

Alopecia

Question 5

Alteplase differs from streptokinase in which of the following ways?

Accepted Answer

It activates plasminogen that is bound to fibrin.

Answer

It has a longer duration of action.

Answer

It is derived from human kidney cells.

Answer

It is less expensive.

Question 6

All of the following are true about heparin except:

Accepted Answer

It can only be administered in vivo

Answer

Its antidote is protamine sulfate

Answer

It cannot be given orally

Answer

It increases APTT

Question 7

Streptokinase and Urokinase are contraindicated in:

Accepted Answer

Intracranial malignancy

Answer

Pulmonary Embolism

Answer

Arteriovenous fistula

Answer

Thrombophlebitis

Question 8

Warfarin embryopathy is due to the action of:

Accepted Answer

Osteocalcin

Answer

Osteophysin

Answer

Osteotensin

Answer

Osteogenin

Question 9

Which of the following is an antifibrinolytic agent?

Accepted Answer

Epsilon aminocaproic acid

Answer

Dabigatran

Answer

Protamine

Answer

Alteplase

Question 10

In the management of pulmonary emboli, alteplase is infused for how long?

Accepted Answer

1-3 hours

Answer

4-6 hours

Answer

7-9 hours

Answer

10-12 hours

Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation — MCQs

On this page

Practice by Chapter

Want unlimited practice?